Professional Role and Responsibilities
Dr. Glen Stettin serves as Senior Vice President and Chief Innovation Officer at Evernorth Health Services, the health services division of The Cigna Group. In this capacity, he leads the clinical products channel, including oversight of Therapeutic Resource Centers℠, trend and formulary management, and the development and execution of integrated health solutions. His role encompasses driving innovation, leveraging data and clinical expertise to shape and enhance healthcare delivery and patient outcomes.
Career Background and Industry Experience
Dr. Stettin has a distinguished clinical and leadership background spanning over two decades. Before Evernorth, he held a senior leadership position at Express Scripts, which Evernorth succeeded. There, he was responsible for all aspects of research, innovation, and clinical strategy. His tenure at Medco extended for 17 years where he held leadership roles across clinical, operations, technology, and product organizations, signaling broad operational and strategic expertise in pharmacy benefit management and health services.
Education and Medical Training
- Bachelor’s degree: Lehigh University
- Medical degree: Medical College of Pennsylvania
- Residency: Internal Medicine residency completed at the University of California, San Francisco (UCSF)
- Leadership during training: Served as Medical Chief Resident at UCSF's Moffitt-Long Hospital, underscoring early leadership capabilities in clinical settings.
Professional Expertise and Focus
Dr. Stettin is recognized as an accomplished clinician and self-described data geek, with a strong passion for innovation and evidence-based, data-driven healthcare to improve clinical outcomes and lower healthcare costs. His focus includes:
- Clinical product innovation and management: Development of products that impact therapy management and patient care.
- Research and development: Championing research initiatives aimed at accelerating healthcare transformation and clinical trials access.
- Data-driven healthcare response: Led efforts within Evernorth to utilize real-time data and clinical knowledge effectively in responding to the COVID-19 pandemic.
- Mental health: An acknowledged voice on trends in mental health medication use, particularly medications addressing depression, anxiety, and insomnia.
Strategic Initiatives and Partnerships
- Oversees Evernorth’s collaboration with the NBA and WNBA through a multi-year partnership focused on enhancing community health and vitality, integrating the link between physical and mental health wellness.
- Leadership in the Evernorth Research Institute, which focuses on creating actionable intelligence to improve health outcomes across populations.
- Involved in clinical trial connectivity programs, facilitating patient access to potentially lifesaving treatments.
Leadership and Influence
Dr. Stettin’s role places him at the intersection of clinical innovation and health services strategy within a major healthcare organization. His leadership supports Evernorth's positioning as a significant innovator in health services under the broader Cigna umbrella, leveraging advanced analytics and integrated health solutions.
He is frequently cited in healthcare communications and industry events as an expert on drug pricing trends, clinical innovation labs, and health services innovation.
Geographic and Organizational Details
- Based in St. Louis, Missouri, United States, where a significant portion of Evernorth’s innovation and research team operates.
- Reports within a corporate structure where Evernorth functions as a strategic health services division of Cigna, integrating pharmacy solutions and clinical innovation.
This detailed profile encapsulates Dr. Glen Stettin’s leadership executive role, clinical background, and innovation-driven approach in advancing healthcare products and solutions at Evernorth Health Services.
